TEVA 7334 (Mycophenolate Mofetil 250 mg)
Pill with imprint TEVA 7334 is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Teva Pharmaceuticals USA.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7334
Mycophenolate Mofetil
- Imprint
- TEVA 7334
- Strength
- 250 mg
- Color
- Blue & Orange
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-7334
More about mycophenolate mofetil
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (53)
- Drug images
- Pricing & coupons
- En español
- Drug class: selective immunosuppressants
Patient resources
- Drug Information
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
- Other brands
- CellCept
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.